Biomarkers of Fluorouracil Toxicity: Insight From the PETACC-8 Trial

Overview of attention for article published in JAMA Oncology, May 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)

Mentioned by

twitter: 11 X users

facebook: 1 Facebook page

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 4 public wall posts from 1 users.

JAMA Oncology, 18 May 2016

Compared with fluorouracil monotherapy, modern multidrug combination therapies based on fluorouracil (eg, fluorouracil…

JAMA Oncology, 27 Jan 2016

Are gene variants for DPD deficiency clinically useful now in managing colon cancer? http://ja.ma/1QctN23

JAMA Oncology, 22 Jan 2016

This invited commentary reviews the utility and limitations of using gene variants for DPD deficiency as a predictor of…

JAMA Oncology, 22 Jan 2016

Compared with fluorouracil monotherapy, modern multidrug combination therapies based on fluorouracil (eg, fluorouracil…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.